Tech Company Financing Transactions
Kala Pharmaceuticals Funding Round
Kala Pharmaceuticals, operating out of Watertown, scored $11.5 million in funding from Crown Venture Fund, Lux Capital and Polaris Partners.
Transaction Overview
Crown Venture Fund (Lead Investor) (Richard Robb)
Lux Capital (Robert Paull)
Polaris Partners (Kevin Bitterman)
Third Rock Ventures (Robert Tepper)
Company Information
Watertown, MA 02472
USA
Management Team
Browse more venture capital transactions:
Prev: 3/1/2013: MicroTransponder venture capital transaction
Next: 3/1/2013: Julep Beauty venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs